These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 769501)

  • 21. Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection.
    Tyrrell DA; Buckland RA; Schild GC; Freestone DS; Chinn S; Slepushkin AN
    Postgrad Med J; 1973 Mar; 49(569):200-2. PubMed ID: 4802537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Specific and nonspecific factors of humoral immunity in the early period of influenza virus immunization].
    Kulevich EE
    Vopr Virusol; 1973; 18(4):438-43. PubMed ID: 4786165
    [No Abstract]   [Full Text] [Related]  

  • 23. Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology.
    Petrescu A; Mihail A; Samuel I; Teodosiu O; Isaia G; Ganea E; Motaş C
    Virologie; 1979; 30(2):109-15. PubMed ID: 111408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological reactions in the secretions of volunteers vaccinated against influenza by aerosol and intranasally].
    Pershin BB; Romanov VL; Kvirikadze VV; Stefani DV; Torichneva LIu
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Mar; (3):35-9. PubMed ID: 373335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza.
    Kilbourne ED
    Prev Med; 1974 Dec; 3(4):461-5. PubMed ID: 4438281
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of respiratory virus infection by locally applied interferon.
    Merigan TC; Reed SE; Hall TS; Tyrrell DA
    Lancet; 1973 Mar; 1(7803):563-7. PubMed ID: 4120640
    [No Abstract]   [Full Text] [Related]  

  • 28. Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics.
    Sano K; Ainai A; Suzuki T; Hasegawa H
    Expert Rev Vaccines; 2018 Aug; 17(8):687-696. PubMed ID: 30092690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza].
    Shvartsman IaS; Tsybul'skaia NV; Ispolatova AV
    Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100
    [No Abstract]   [Full Text] [Related]  

  • 30. Secretory antibodies in respiratory virus infections.
    Petrescu A
    Virologie; 1984; 35(2):133-8. PubMed ID: 6330974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.
    Potter CW; Jennings R; McLaren C; Edey D; Stuart-Harris CH; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):353-62. PubMed ID: 1059705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children.
    Boyce TG; Gruber WC; Coleman-Dockery SD; Sannella EC; Reed GW; Wolff M; Wright PF
    Vaccine; 1999 Aug; 18(1-2):82-8. PubMed ID: 10501238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An attenuated influenza virus vaccine: Reactogenicity, transmissibility, immunogenicity, and protective efficacy.
    Lauteria SF; Kantzler GB; High PC; Lee JD; Waldman RH
    J Infect Dis; 1974 Oct; 130(4):380-3. PubMed ID: 4475057
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative studies in influenza vaccines].
    Kunz C; Wiedermann G; Dostal V
    Wien Med Wochenschr; 1975 Oct; 125(40):581-2. PubMed ID: 1226778
    [No Abstract]   [Full Text] [Related]  

  • 35. Secretory immunity in influenza.
    Shvartsman YS; Grigorieva SK
    J Infect Dis; 1979 Dec; 140(6):837-43. PubMed ID: 541522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of secretory antibody following oral antigen administration.
    Waldman RH; Bergmann KC
    Adv Exp Med Biol; 1987; 216B():1677-84. PubMed ID: 3425454
    [No Abstract]   [Full Text] [Related]  

  • 37. Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration.
    Liu Q; Zheng X; Zhang C; Shao X; Zhang X; Zhang Q; Jiang X
    J Med Virol; 2015 Nov; 87(11):1807-15. PubMed ID: 25959372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to influenza in ferrets. VI. Immunization with adjuvanted vaccines.
    Potter CW; Jennings R; McLaren C
    Arch Gesamte Virusforsch; 1973; 42(3):285-96. PubMed ID: 4754182
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunological problems of influenza virus infections].
    Schmidt J; Süss J; Stelzner A
    Arch Exp Veterinarmed; 1978; 32(3):377-90. PubMed ID: 81042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The defense of the lung: studies of bronchoalveolar cells and secretions.
    Johnson JE; Waldman RH
    Trans Am Clin Climatol Assoc; 1973; 84():237-44. PubMed ID: 4125737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.